Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy. - Moehle MS; Bender AM; Dickerson JW; Foster DJ; Qi A; Cho HP; Donsante Y; Peng W; Bryant Z; Stillwell KJ; Bridges TM; Chang S; et al. (ACS pharmacology & translational science, 2021)